Authors' Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinics (São Paulo, Brazil) Brazil), 2019, Vol.74, p.e1517-e1517, Article e1517
Hauptverfasser:	Gomes, Luis Eduardo Miani, da Silva, Francesca Aparecida Ramos, Pascoal, Lívia Bitencourt, Ricci, Renato Lazarin, Nogueira, Guilherme, Camargo, Michel Gardere, de Lourdes Setsuko Ayrizono, Maria, Fagundes, João José, Leal, Raquel Franco
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal Brazil Comments Crohn Disease Humans Immunosuppressive Agents Infliximab MEDICINE, GENERAL & INTERNAL
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!